Enanta Pharmaceuticals SG&A Expense (Annual) Trends

Enanta Pharmaceuticals Inc (ENTA)

10.05 -0.42 (-4.01%) USD | NASDAQ | Sep 27, 16:00

10.02 -0.03 (-0.30%) After-Hours: 20:00

SG&A Expense (Annual) Chart

Historical SG&A Expense (Annual) Data

View and export this data back to 2010. Upgrade now.

Date	Value
September 30, 2023	52.89M
September 30, 2022	45.48M
September 30, 2021	32.54M
September 30, 2020	27.36M
September 30, 2019	26.25M
September 30, 2018	23.44M
September 30, 2017	20.75M

Date	Value
September 30, 2016	16.97M
September 30, 2015	13.54M
September 30, 2014	10.02M
September 30, 2013	6.183M
September 30, 2012	5.302M
September 30, 2011	5.036M
September 30, 2010	6.105M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Annual) Range, Past 5 Years

26.25M

Minimum

2019

52.89M

Maximum

2023

36.90M

Average

32.54M

Median

2021

SG&A Expense (Annual) Benchmarks